Richard Pzena Bristol Myers Squibb CO Transaction History

Pzena Investment Management LLC

$29.9 Billion
Q3 2025

A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pzena Investment Management LLC holds 14,901,604 shares of BMY stock, worth $698 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares

14,901,604

Previous 14,843,475 0.39%

Holding current value

$698 Million

Previous $687 Million 2.19%

% of portfolio

2.25%

Previous 2.3%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$43.31 - $48.98 $2.52 Million - $2.85 Million	58,129 Added 0.39%	14,901,604 $672 Million
Q2 2025 Jul 25, 2025	BUY	$44.12 - $59.6 $61.1 Million - $82.5 Million	1,384,649 Added 10.29%	14,843,475 $687 Million
Q1 2025 May 02, 2025	BUY	$53.9 - $63.11 $8.49 Million - $9.94 Million	157,527 Added 1.18%	13,458,826 $821 Million
Q4 2024 Feb 07, 2025	SELL	$51.92 - $59.94 $46.8 Million - $54 Million	-900,447 Reduced 6.34%	13,301,299 $752 Million
Q3 2024 Nov 08, 2024	BUY	$39.66 - $51.75 $2.67 Million - $3.49 Million	67,409 Added 0.48%	14,201,746 $735 Million

Q2 2024 Aug 02, 2024	BUY	$40.25 - $52.99 $74.1 Million - $97.5 Million	1,840,424 Added 14.97%	14,134,337 $587 Million
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $322 Million - $365 Million	6,701,097 Added 119.82%	12,293,913 $667 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $32.4 Million - $38.7 Million	668,622 Added 13.58%	5,592,816 $287 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $34.5 Million - $38.6 Million	596,625 Added 13.79%	4,924,194 $286 Million
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $11.7 Million - $13 Million	-184,216 Reduced 4.08%	4,327,569 $277 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $42.8 Million - $48.5 Million	651,213 Added 16.87%	4,511,785 $313 Million
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $9.01 Million - $10.7 Million	-131,559 Reduced 3.3%	3,860,572 $278 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $23,283 - $13.8 Million	-179,101 Reduced 4.29%	3,992,131 $284 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $39.6 Million - $43.6 Million	545,445 Added 15.04%	4,171,232 $321 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $152 Million - $182 Million	2,470,079 Added 213.73%	3,625,787 $265 Million
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $1.19 Million - $1.39 Million	-22,235 Reduced 1.89%	1,155,708 $72.1 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $16.7 Million - $19.5 Million	-281,980 Reduced 19.31%	1,177,943 $69.7 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $84,754 - $92,297	-1,369 Reduced 0.09%	1,459,923 $97.6 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $288,511 - $324,489	4,862 Added 0.33%	1,461,292 $92.3 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $21,132 - $23,947	366 Added 0.03%	1,456,430 $90.3 Million
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $381,564 - $422,824	-6,644 Reduced 0.45%	1,456,064 $87.8 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $20.5 Million - $24 Million	-373,749 Reduced 20.35%	1,462,708 $86 Million
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $32.5 Million - $47.3 Million	-701,418 Reduced 27.64%	1,836,457 $102 Million
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $1.96 Million - $2.56 Million	-39,851 Reduced 1.55%	2,537,875 $163 Million
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $110 Million - $131 Million	2,577,726 New	2,577,726 $131 Million

Others Institutions Holding BMY

# of Institutions

2,682

Shares Held

1.58B

Call Options Held

28.2M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track Richard Pzena's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.

Account